RenovoRx, Inc. is a clinical-stage biopharmaceutical company, which engages in the development of a therapy platform to deliver chemotherapy. Its therapy platform includes RenovoTAMP, a therapy platform designed for targeted delivery of chemotherapy enabling localized treatment of solid tumors. The company was founded by Ramtin Agah and Kamran Najmabadi in 2009 and is headquartered in Mountain View, CA.
Sector:
Health Technology
Industry:
Medical Specialties
Employees:
17
Frequently Asked Questions
Market cap, also known as market capitalization, is the total market value of a company. It's calculated by multiplying the current market price by the total number of shares outstanding. RenovoRx Inc market cap is $45.45M.
52 week high is the highest price of a stock in the past 52 weeks, or one year. RenovoRx Inc 52 week high is $2.59 as of November 22, 2026.
52 week low is the lowest price of a stock in the past 52 weeks, or one year. RenovoRx Inc 52 week low is $0.77 as of November 22, 2026.
RenovoRx Inc stock price today is $0.942.
RenovoRx Inc stock price yesterday was $1.05.
The Price-to-Earnings (or P/E) ratio is a commonly used tool for valuing a company. It's calculated by dividing the current share price by the earnings per share (or EPS). It can also be calculated by dividing the company's Market Cap by the Net Profit. RenovoRx Inc's P/E ratio is -3.04.
The Price-to-Book (P/B) ratio is a commonly used tool for valuing a company. It's calculated by dividing a company's market capitalization by its book value. RenovoRx Inc P/B ratio is 4.8897.
The 50-day moving average is a frequently used data point by active investors and traders to understand the trend of a stock. It's calculated by averaging the closing stock price over the previous 50 trading days. RenovoRx Inc 50-day moving average is $1.35.